The Hearing Review
  • Hearing Loss
    • Health & Wellness
    • Hearing Disorders
    • Patient Care
    • Prevention
    • Tinnitus
    • Vestibular
  • Products
    • Amplification
    • Hearing Aids
    • Implants & Bone Conduction
    • Tinnitus Devices
    • Vestibular Solutions
    • Accessories
  • Practice Building
    • Marketing
    • Office Services
    • Practice Management
  • Inside Hearing
    • Events
    • Industry News
    • People
    • Organizations
    • Regulation
    • Research
  • Resources
    • Videos
    • Webinars
    • White Papers
  • Edition Archive

Select Page

Tag: Thomas Meyer

All

Latest
Experts Confirm Betahistine’s Clinical Utility in the Treatment of BPPV

Experts Confirm Betahistine’s Clinical Utility in the Treatment of BPPV

Altamira Therapeutics reports that a meta-analysis of nine randomized controlled trials has shown that the oral administration of betahistine, along with the Epley maneuver, is more effective than Epley's maneuver alone.

  • Auris Medical Completes Enrollment in Phase 2 Study for Vertigo Drug

  • Auris Medical Announces Notice of Allowance for European Patent Application

  • Auris Medical Receives Notice of Allowance from Patent Offices for Vertigo Drug

  • Auris Medical Forms Scientific Advisory Board for Tinnitus Research and Development

  • Auris Medical Announces Publication on Study Showing Effect of Betahistine on Vertigo Symptoms

  • Auris Medical Announces Clinical Results from AM-111 Phase 3 Clinical Trial

All

Latest
Auris Medical Holding AG Announces Patient Recruitment for Phase 3 Clinical Trial of Tinnitus Drug is Complete

Auris Medical Holding AG Announces Patient Recruitment for Phase 3 Clinical Trial of Tinnitus Drug is Complete

Keyzilen® is a small molecule N-methyl-D-aspartate (NMDA) receptor antagonistin that is in development for treatment of acute tinnitus of the inner ear.

  • Auris Medical Holding AG Completes Patient Enrollment in Phase 3 Clinical Trial of Hearing Loss Drug

    Auris Medical Holding AG Completes Patient Enrollment in Phase 3 Clinical Trial of Hearing Loss Drug

  • Auris Announces FDA Fast Track Designation For AM-111

    Auris Announces FDA Fast Track Designation For AM-111

  • Auris Medical Collaborates with Cochlear on Clinical Trial

    Auris Medical Collaborates with Cochlear on Clinical Trial

All

Latest
Sorry, No Posts Found
Sorry, No Posts Found

MEDQOR INFORMATION SERVICES NETWORK

  • 24×7
  • Axis Imaging News
  • Clinical Lab Products
  • Orthodontic Products
  • Physical Therapy Products
  • Plastic Surgery Practice
  • Rehab Management
  • RT: For Decision Makers in Respiratory Care
  • Sleep Review

Resource Center

  • Edition Archive
  • Podcasts
  • Webinars
  • White Papers
  • Videos
  • Consumer Site

Helpful Links

  • Marketing Solutions
  • Subscribe
  • Contact Us

Designed by Elegant Themes | Powered by WordPress

  • Privacy Policy
  • Terms of Service
  • Copyright